Shanxi Jinbo Biological Pharmaceutical

Shanxi Jinbo Biological Pharmaceutical is a leading Chinese biopharmaceutical company specializing in the research, development, and manufacturing of recombinant humanized collagen and synthetic biology-based products. The company is renowned for its proprietary Recombinant Humanized Type III Collagen, which is used in medical aesthetics, wound care, and gynecological health. Jinbo Bio operates a full industrial chain from basic research to industrialization, providing innovative solutions for anti-aging and tissue repair. Their flagship products include medical devices and functional skincare items that leverage high-purity, bioactive collagen. The company achieved a significant milestone by becoming the first to mass-produce recombinant humanized collagen with a stable triple helix structure. Listed on the Beijing Stock Exchange, Jinbo Bio continues to expand its portfolio into diverse therapeutic areas including dermatology and surgery.